ISDE 2021 is pleased to welcome the confirmed speakers for the 17th ISDE World Congress on Esophageal Diseases taking place virtually from September 27 to 30, 2021.
Dr. Alcindor is Director of Medical Oncology at the MUHC and Associate Professor at McGill University in Montreal, Canada. He is co-chair of the Upper GI Group of the Canadian Cancer Trials Group and a member of the ASCO Meeting Scientific Committee.
David Armstrong has research interests in GERD, dyspepsia, nutrition, colon cancer screening, and endoscopy quality. He is Past-President of the Canadian Association of Gastroenterology, Chair of the Canadian National Colon Cancer Screening Network, Treasurer of the International Working Group for the Classification of Oesophagitis, and Chair of the Guidelines Committee for the World Gastroenterology Organization.
Shanda H. Blackmon, M.D., M.P.H. is a minimally invasive thoracic surgeon. She completed Cardiothoracic Surgery Residency at Baylor College of Medicine, in Houston, Texas. She was awarded the Clinical Instructorship position in thoracic surgical oncology at MDACC, until she was recruited to build and lead the Division of Thoracic Surgery at Houston Methodist Hospital. Dr. Blackmon was Chief of Thoracic Surgery at Houston Methodist Hospital for eight years, serving as the Director of the Thoracic Tumor Board and Director of the Lung Cancer Screening Program. She has led esophageal support groups for 16 years. She has now joined Mayo Clinic in Rochester, MN, where she currently practices in the Division of Thoracic Surgery. She holds a patent for a novel esophageal anastomotic device, leads the Mayo Clinic Esophageal Tumor Board and developed an App that is a virtual patient management platform. She leads a specialized team for complex esophageal reconstruction, serves as a Champion for 3D anatomic modeling for complex thoracic resections. She was just appointed as the Medical Director of Mayo Clinic Digital Properties. She is Board-certified by ABS & ABTS, and currently has the rank of Professor at Mayo Clinic. She serves on the following boards or councils: TSF, STS, WTS, ATS, and STSA. Dr. Blackmon has published over 100 peer-reviewed manuscripts, given over 200 oral presentations, is internationally recognized, published more than 100 instructional videos (@ShandaBlackmon for Twitter). She is a current Deputy Editor for The Annals of Thoracic Surgery, Past-President of Women in Thoracic Surgery, Secretary/Treasurer of TSF & STSA, and serves as a Council Chair for the Board of Directors for STS.
Prof. Boeckxstaens obtained his medical degree in 1987 and his Ph.D. degree in 1991. In 1994, he completed his clinical training in Internal Medicine / Gastroenterology and accepted a staff position in the Department of Gastroenterology & Hepatology at the Academic Medical Center in Amsterdam, The Netherlands. In 2005, he became Professor of Neurogastroenterology at the Academic Medical Center and was appointed co-chair of the Department of Gastroenterology and Head of the gastrointestinal research. In 2007, he accepted a full professorship in Medicine at the University of Leuven (Belgium) in the Department of Gastroenterology. He received several national and international prizes and received the prestigious European Research Council (ERC), Advanced Grant, in 2014 and in 2019. Currently, he is Associate Editor of Gut, and has published over 300 peer-reviewed manuscripts, and has an H-index of 64. The scientific expertise of the research group of Prof. Boeckxstaens relates to neurogastroenterology and neuro-immune interactions in the gastrointestinal tract. The mechanisms leading to diseases such as achalasia, gastroesophageal reflux disease, irritable bowel disease, inflammatory bowel disease, chronic constipation, functional dyspepsia, and postoperative ileus have been the main topics of interest over the past 20 years.
"Elena Bonora is Associate Professor in Medical Genetics at the University of Bologna. After graduating from Biological Sciences, University of Bologna, she acquired her Ph.D. in Clinical medicine, Human Genetics, at the University of Oxford, UK. She is specialized in Applied Genetics and Medical Genetics. She has authored more than 70 articles in peer-reviewed journals, H-index=26.
Her research focuses on the identification of disease genes in complex and Mendelian diseases, including familial thyroid cancer and hereditary breast cancer. She is also involved in international collaboration on esophageal adenocarcinomas. Her relevant discoveries in oncology include:
The identification of OXPHOS complex I mutations in sporadic thyroid carcinoma with oncocytic features, (Bonora et al, Cancer Research, Cancer 2006; Gasparre et al, PNAS 2007);
The identification of the novel mutation underlying a familial form of thyroid cancer with oncocytic features (Diquigiovanni et al, Int J Cancer, 2018);
The molecular characterization of tumor subpopulations in esophageal adenocarcinoma (Isidori et al, CTG 2020)
The recent discovery of ROS1 and RASAL1 as predisposing genes for hereditary breast cancer (Isidori et al, Cancers 2020).
Professor Michael Bourke of the University of Sydney is Director of Gastrointestinal Endoscopy at Westmead Hospital. He is previous Co-editor of Endoscopy (Journal of the European Society of Gastrointestinal Endoscopy, 2011-2019), past Chairman of the Australian Gastrointestinal Endoscopy Association (2007-2009), the Australian and New Zealand Endoscopy Leaders Forum, and the NSW Department of Health Bowel Cancer Screening Program Advisory Group and Colonoscopy Study Implementation Committee. He is a member and a former Councillor of the Gastroenterology Society of Australia (GESA), the American Society for Gastrointestinal Endoscopy, and the American Gastroenterology Association.
Professor Bourke is a world-renowned international authority in gastrointestinal endoscopy. His special interests include colonoscopy, advanced endoscopic resection (EMR or ESD) of mucosal neoplasia, polyps, and early cancer at all sites in the gastrointestinal tract, third space (submucosal) endoscopy, and ERCP. Through scientific research, he has invented, pioneered, developed and established key techniques in advanced therapeutic endoscopy. He has published over 300 peer-reviewed research papers, expert reviews and editorials with more than 9000 citations, in the leading Gastroenterology and Endoscopy journals.
Professor Bourke is a co-founder of the National Endoscopy Training Initiative (NETI) and Convenor of the Sydney International Endoscopy Symposium (2008-2021, https://www.sies.org.au). He has been an invited speaker at more than 250 international conferences including all 5 continents, delivering numerous lectures and live Endoscopy demonstrations. He has received numerous Visiting Professorships, honours, and awards including the GESA Distinguished Clinician Award for contributions to the specialty, research, and the society (2012), the Christopher Williams medal from British Society of Gastroenterology (2017) and the GESA Distinguished Researcher Prize (2019).
Albert J (Arjan) Bredenoord (1977), MD is Consultant Gastroenterologist at the Amsterdam University Medical Center and professor of Neurogastroenterology & Motility at the University of Amsterdam.
After his Medicine studies in Antwerp, Belgium he worked on several clinical research projects on GI motility at the University of Utrecht, the Netherlands resulting in a PhD thesis on gastroesophageal reflux disease in 2006. His clinical training was performed in Nieuwegein, the Netherlands and at the Royal London Hospital in London, UK. He currently works as a consultant Gastroenterologist at the Amsterdam University Medical Center where he is dedicated to patients care, scientific research and education in the field of benign esophageal diseases.
Dr Bredenoord’s main focus is on achalasia, reflux disease and eosinophilic esophagitis. He is one of the pioneers of high-resolution manometry and impedance monitoring of the esophagus. The esophageal clinic in the AMC Amsterdam hosts the largest population of benign esophageal diseases in the Netherlands. Dr Bredenoord is an author of over 250 papers, books and book chapters and organizes regular courses in Europe, North America and Asia. Dr Bredenoord is President of the European Society of Eosinophilic Esophagitis EUREOS, member of the UEG Scientific Committee and co-founder of the International HRM working group.
Dr. Tim Bright graduated from Adelaide University and obtained his general surgical fellowship from the Royal Australian College of Surgeons in 2006. He then undertook a Masters of Surgery and further post-fellowship training at the Northern Oesophago- Gastric Cancer Unit in Newcastle UK. He was appointed consultant and senior lecturer in surgery on the Oesophago-Gastric Surgery Unit at Flinders Medical Centre in 2010 and has been Head of Unit since 2014. He is the immediate past chair of the training committee and sat on the Executive of the Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA).
Dr Bright's interests include oesophago-gastric cancer and benign upper gastrointestinal disorders, as well as interventional upper GI endoscopy including EUS
Professor Wendy Brown is an Upper GI and Bariatric Surgeon. She is the Surgical Programme Director and Chair of the Monash University Department of Surgery at the Alfred Hospital. In addition, she is the Clinical Director of the ANZ Bariatric Surgery Registry and Victorian State Upper GI Cancer Registry.
Her sub-specialist interests are oesophago-gastric cancer, gastrooesophageal reflux disease, and bariatric surgery. Her research interests include health outcomes from bariatric surgery, animal models of bariatric surgery, and basic mechanisms underlying satiety.
She is Chair of the International Federation for Surgery for Obesity and Metabolic Disorders (IFSO) Global Registry, Past President of OSSANZ and ANZGOSA, Past Senior Examiner in General Surgery for the RACS, Past- Chair of the Scientific Committee of the IFSO.
She was awarded the prestigious RACS John Mitchell Crouch Fellowship for Surgical Research Excellence in 2018.
Christiane J. Bruns has served as Professor and Director of the Department of General, Visceral, Cancer and Transplant Surgery at the University of Cologne since 2016. She is Vice Director of the Comprehensive Cancer Center Cologne Bonn Düsseldorf Aachen, and Scientific Coordinator of the Else-Kröner-Forschungskolleg Cologne, "Clonal dynamics in cancer" since 2017. From 1997 to 1999 she absolved her postdoctoral fellowship at the Department of Cancer Biology, University of Texas M. D. Anderson Cancer Center, under the guidance of Prof. I. J. Fidler, supported by the German Research Society (DFG). Professor Bruns is an expert in GI Surgical Oncology and Minimal-Invasive/Robotic Surgery. Her main clinical and research focus is upper GI cancer, pancreatic cancer, oligometastasis with a strong interest in therapy resistance and minimal residual disease. She has authored a number of publications and has many accomplishments to her name including 2020 Honorary Member Upper Gastrointestinal Surgery of the European Board of Surgery and Thoracic Surgery (U.E.M.S.), 2018 Member of Leopoldina Academy of Sciences, 2003 Von-Langenbeck-Prize of the German Society of Surgery and recipient of the Curt-Bohnewand-Award of the Medical Faculty of the Ludwig Maximillian University of Munich in 2005. She is the principal investigator of the 2019 initiated BMBF01KG186 CARDIA-Trial.
Professor of Anesthesia at McGill University and Associate Professor in the School of Dietetics and Human Nutrition at McGill University.
Previously Wesley Bourne Professor and Chairman
Dr. Catenacci is an active basic and clinical researcher, focusing on the treatment of gastroesophageal (esophagus, gastroesophageal junction, and stomach) cancers. His bench-to-bedside translational research has an overarching goal to validate and improve personalized diagnostics, treatment, immunotherapy, and precision medicine for gastroesophageal cancer and other GI cancers. A major focus of his research is on the quantification of tumor genetic molecular heterogeneity both between individuals with gastroesophageal cancer, but importantly also within a given individual within one tumor site, and from one tumor site to another, and how this impacts personalized targeted therapeutic approaches. Additionally, Dr. Catenacci designs and executes novel clinical trials to implement treatment strategies based on these laboratory and clinical discoveries.
Professor of Surgery Department of Gastroenterology, University of São Paulo School of Medicine, Digestive Surgery Division. Specialized in GI surgery, including Surgical Oncology, mainly esophageal diseases. Responsible for graduation and post-graduate courses, medical residence training in Digestive Surgery, including video surgery and robotics. Member of ISDE, Secretary-General of the 8th ISDE World Congress-São Paulo/Brazil/2001. Past member, and afterward, president of the Barret's Esophagus Research Committee. Federation Governor of South America of ISDE/Member of the Executive Committee, 2006-2008.
Prof.S M Chandramohan is the Director of the International student program and Professor of upper G I Surgery at Sri Ramachandra Institute of Higher Education and research, India.
He was the first director of the Institute of Surgical Gastroenterology, Madras Medical College and Founder and President of ESOINDIA.www.esoindia.org
Dr. Chang’s clinical research focuses on the development of endoscopic modalities for cancer diagnosis, staging, and therapy. He has pioneered the development of Endoscopic Ultrasound (EUS)-guided FNA, and subsequently, EUS-guided FNI (fine needle injection) and has written more than 300 publications and book chapters regarding its utility in GI malignancies. He has conducted numerous clinical trials on the development of new biologic agents against esophageal and pancreatic cancers.
His clinical expertise in pancreatico-biliary endoscopy includes EUS, EUS-guided FNA, and FNB, EUS-guided Intervention (celiac ganglion neurolysis, choledochoduodenostomy, EUS-guided liver biopsy, and portal pressure measurement, etc), and endoscopic retrograde cholangiopancreatography (ERCP). For esophageal and gastric interventions, his expertise includes endoscopic treatment of gastro esophageal reflux disease (GERD), as well as endoscopic mucosal resection, laser-induced endomicroscopy, radiofrequency, and cryoablation therapy for Barrett’s and esophageal cancer. He is also considered the West Coast expert in Per-oral endoscopic myotomy (POEM), endoscopic submucosal dissection (ESD), and endoscopic sleeve gastroplasty (ESG) for obesity.
Dr. Chen obtained MD from Hebei Medial University China and PhD from Montreal University Canada. He has been working for 35 years in thoracic surgery and focusing on esophageal diseases. He participated in AJCC project to define the 7th (2009) and 8th Edition (2016) of TNM staging for esophageal cancer.
Andrew Chew is currently appointed as Consultant Surgeon on the Esophagogastric Unit at Flinders Medical Center, Adelaide Australia. His long-term passion has been in global surgery, with the eye on capacity building of the surgical workforce in low and middle-income countries. He has worked in several countries in Africa, including 3 years in Niger in the 1990s and more recently as Program Director of general surgery training in Soddo Christian Hospital, Ethiopia under the auspices of the Pan African Academy of Christian Surgeons from January 2015 – Jan 2020, where he assisted 8 trainees to obtain their fellowship from the College of Surgeons of East, Central and Southern Africa (COSECSA) – the largest Surgical Training Institute in Sub-Saharan Africa. He has also been a COSECSA examiner since 2015 and has served on the curriculum committee. His clinical and surgical experience straddles practice in both resource-rich and resource-limited environments, performing the gamut of general surgery whilst in Africa.
Philip Chiu is currently Professor of Division of Upper GI and Metabolic Surgery, Department of Surgery, Director of Shaw Endoscopy Center, Institute of Digestive Disease; Director of CUHK Jockey Club Minimal Invasive Surgical Skills Center; Director of CUHK Chow Yuk Ho Technology Center for Innovative Medicine and Assistant Dean (External Affairs), Faculty of Medicine, Chinese University of Hong Kong. Professor Chiu graduated from the Faculty of Medicine, the Chinese University of Hong Kong in 1994 with two scholarships. He received a Doctor of Medicine at CUHK in 2009. Prof. Chiu was the first to perform ESD for treatment of early GI cancers (2004) and the first to perform Per-oral Endoscopic Myotomy (P.O.E.M.)(2010) in Hong Kong. His research interests include esophageal cancer management, minimally invasive and robotic esophagectomy, novel endoscopic technologies for diagnosis and treatment of early GI cancers, endoscopic surgery as well as robotics for endoluminal surgery.
Jonathan Cools-Lartigue is an attending thoracic and upper gastrointestinal surgeon at the McGill University Health Centre and an Assistant Professor in the Department of Surgery and Oncology. His recruitment follows his fellowship training at the Memorial Sloan Kettering Cancer Centre in conjunction with the New York-Presbyterian Hospital.
Dr Darling is a Professor of Surgery in the Division of Thoracic Surgery and the Kress Family Chair in Esophageal Cancer at University Health Network and the University of Toronto. She is the Clinical Lead for Thoracic Cancers for Cancer Care and Lung Cancer Screening
During his medical studies at Leiden University (the Netherlands), Michiel de Maat initiated his first oncological research projects within the translational surgical group of professors Cornelius van de Velde and Rob Tollenaar. This lead to a visit to the John Wayne Cancer Institute (JWCI, Santa Monica, US) in 2002 where he was given the opportunity to train basic scientific research skills in the Department of Molecular Oncology under the supervision of dr. Dave Hoon. The next four years he interrupted his medical studies to build a collaboration between the departments of surgical oncology at Leiden University and the JWCI and focused these translational projects on epigenetic biomarkers in gastrointestinal cancers. In 2008 he obtained his M.D (with honors) and his Ph.D. in 2010 based on the obtained data. In 2011 he started his surgical training in the South of the Netherlands (trainers dr. Ton Hoofwijk and professor Laurents Stassen) and registered as a gastrointestinal as well as an oncological surgeon in 2016. After a fellowship in the Antwerp university hospital (Belgium, head professor Guy Hubens) in bariatric, robotic and upper-GI surgery he continued as a fellow in upper-GI robotic surgery at the University Medical Center Utrecht (professors Jelle Ruurda and Richard van Hillegersberg). Here he became a staff surgeon in 2018 specialized in upper-GI, robotic, HIPEC (hyperthermic intraoperative peritoneal chemotherapy), and colorectal surgery. In April 2020 he returned to the Antwerp University Hospital as an upper-GI senior staff surgeon to build a regional collaboration in this area for centralized surgical care for esophageal diseases. His research interests are in translational oncology developing individualized patient therapy by using organoid models and (serum) biomarkers.
Evan S. Dellon, MD, MPH, is a Professor of Medicine and Adjunct Professor of Epidemiology at the University of North Carolina School of Medicine in Chapel Hill. Dr. Dellon received his undergraduate degree from Brown University and his medical degree from Johns Hopkins School of Medicine. He completed an internship and residency in Internal Medicine at Massachusetts General Hospital. He performed a clinical and a research fellowship in Adult Gastroenterology at UNC, during which he also received a Masters of Public Health degree in Epidemiology from the UNC School of Public Health. Dr. Dellon is currently the Director of the UNC Center for Esophageal Diseases and Swallowing (CEDAS) and serves as an Associate Editor for Clinical Gastroenterology and Hepatology. Dr. Dellon’s main research interest is in the epidemiology, pathogenesis, diagnosis, treatment, and outcomes of eosinophilic esophagitis (EoE) and the eosinophilic GI diseases (EGIDs). The goal of his research is to improve the lives of patients with EoE and EGIDs by learning how to better diagnose, treat, and monitor the condition.
Claire Donohoe is a Consultant oesophagogastric surgeon at Trinity St James Cancer Institute in Dublin, Ireland. She has research interests in the immune microenvironment in oesophageal adenocarcinoma, assessing responses to neoadjuvant therapies and medical education.
Dr. Elena Elimova is an Assistant Professor within the Department of Medicine, Division of Medical Oncology at the University of Toronto. Dr. Elimova is board certified in internal medicine and medical oncology. After completing her undergraduate studies and Masters of Science in Biochemistry at Queen’s University, she earned her medical degree from the Memorial University of Newfoundland, Canada. She completed her internship and residency in internal medicine at the University of Ottawa School of Medicine and a clinical fellowship in medical oncology at the University of Toronto, Canada, and subsequently a GI Medical Oncology Fellowship at the MD Anderson Cancer Center where she also worked as a staff physician. The main focus of Elena’s research is to improve the outcomes of patients with gastroesophageal malignancies. She has concentrated on database research, translational research, and the development of clinical trials. Internationally she is a member of the National Cancer Institute Esophagogastric steering task force.
Dr. Swathi Eluri MD, MSCR is an Assistant Professor of Medicine at the University of North Carolina Division of Gastroenterology and Hepatology. She has a clinical and research focus on esophageal diseases. She earned her doctorate of medicine and completed a residency in internal medicine at Johns Hopkins Hospital. She then completed her gastroenterology fellowship at the University of North Carolina Hospital, including a master's in clinical research at the Gillings Global School of Public Health, and an advanced fellowship specializing in esophageal diseases. Dr. Eluri’s research interests include improving screening and surveillance practices in Barrett’s esophagus, the use of non-endoscopic screening modalities, and the application of prognostic risk-stratification tools to improve treatment outcomes in esophageal diseases. Additionally, she has done prior work in evaluating treatment outcomes in eosinophilic esophagitis and esophageal motility disorders.
Gary W. Falk, MD, MS, is currently Professor of Medicine and director of the Esophageal Program at the Hospital of the University of Pennsylvania. He has been involved in clinical research in Barrett’s esophagus, gastroesophageal reflux disease, Helicobacter pylori, esophageal motility disorders, advanced esophageal imaging, and therapeutics, and eosinophilic esophagitis that has resulted in over 200 peer-reviewed publications. The most important of these themes have been in the area of early detection and prevention of esophageal cancer. Research in eosinophilic esophagitis is now focusing on clinical trials of novel therapeutic agents, clinical and biologic aspects of pediatric to adult transition, and participation in the Consortium of Eosinophilic Gastrointestinal Disease Researchers consortium.
Dr. Falk has served nationally in GI professional societies, including being a past president of ASGE, past associate editor of the American Journal of Gastroenterology and past editor of AGA Perspectives. He is currently an associate editor for Diseases of the Esophagus and Treasurer of the ISDE. He is a recipient of the Sidney Cohen University of Pennsylvania GI Fellowship Teacher of the Year Award on two occasions, AGA Distinguished Clinician Award, and AGA Imaging & Advanced Technology Section Research Mentor Award.
Ronnie Fass, MD, is the Medical Director of the Digestive Health Center, Chairman of the Division of Gastroenterology and Hepatology, and head of the Esophageal and Swallowing Program at the MetroHealth Medical Center, Cleveland Ohio. He is also a tenured professor of medicine at Case Western Reserve University. Dr. Fass did his internship and residency in internal medicine at the University of Arizona Health Sciences Center, where he later became a Chief Resident. He then completed a fellowship in gastroenterology at the University of California in Los Angeles where he focused on GI motility and functional bowel disorders.
Dr. Fass has served in leadership positions in many societies. He is the former treasurer of the American Neurogastroenterology and Motility Society as well as the chair of the education committee. The former member of the Nominating Committees of the Upper GI Section and Neurogastroenterology and Motility of the American Gastroenterological Association (AGA). He has served as the chair of the Functional Esophageal Disorders committee for Rome IV, Membership committee of the American Neurogastroenterology and Motility Society, Practice Parameter Committee and Audio Committee of the American College of Gastroenterology (ACG), and the Publication Committee of the American Society of Gastrointestinal Endoscopy (ASGE). He has also served as a member of the management committee of the journal Neurogastroenterology and Motility. Moreover, Dr. Fass has served as a member of many committees in different GI societies. Currently, Dr. Fass serves as a member of the World Gastroenterology Organization (WGO) Guidelines and Publications committee, member of the ACG Digital communications and publications committee, member of The American Forgut Society (AFS) research committee, member of the International Society of Diseases of the Esophagus (ISDE), education committee and the ACG GI on-demand task force steering committee. In addition, Dr. Fass has served on the ANMS/EMS consensus group for Refractory GERD and as a core team member of Chicago Classification 4.0. He is currently a member of the EndoFlip expert's panel working group, Rome.
Dr. Ferguson is a Professor of Surgery at the University of Chicago and the ISDE Executive Director. His clinical interests include esophageal cancer and benign esophageal disease. He has written or edited several books related to the esophagus, including Thoracic Surgery Atlas, Atlas of Minimally Invasive Surgery for Lung and Esophageal Cancer, and Reconstructive Surgery of the Esophagus.
Lorenzo Ferri is the David S. Mulder Chair in Surgery and a Professor in the Departments of Surgery and Oncology at McGill University in Montreal Canada. He is director of the Division of Thoracic Surgery and heads the Upper Gastrointestinal Cancer Program at McGill University, one of North America’s largest and most comprehensive. Dr. Ferri couples this clinical activity with an active translational and fundamental research program investigating the inflammatory basis of cancer progression and is the recipient of numerous peer-review grants, including from the Canadian Institutes of Health Research, Canadian Cancer Society, Department of Defense, and a grand challenge form the Cancer Research UK. Through this work, he has identified the important role of bacterial antigens - pattern-recognition proteins (TLRs and NODs) and host neutrophils/Neutrophil Extracellular Traps in propagating cancer dissemination, thus representing a new paradigm in the metastatic process.
Suzanne Gisbertz finished medical school at the AMC, the University of Amsterdam in 2002. She did her surgical training at UMCU, Utrecht University, and St. Antonius Hospital, Nieuwegein until 2010 and her advanced gastro-intestinal and minimally invasive surgical training at VUmc, Amsterdam until 2012. She got her doctorate in 2009. She is currently a consultant upper-GI surgeon and principal investigator at the Amsterdam UMC, the University of Amsterdam in Amsterdam. She has been proctoring minimally invasive esophagectomies and gastrectomies at different centers in the Netherlands and abroad. Her main research topics are lymph node metastases and extent of lymphadenectomy in esophageal and gastric cancer, minimally invasive upper GI surgery and postoperative outcome, quality of life following upper GI surgery and surgical techniques (e.g. omentectomy vs omentumpreservation in gastrectomy, transhiatal versus transthoracic esophagectomy). She was recently appointed principal investigator at the University of Amsterdam.
Mr. Griffiths graduated with an MBChB (Bachelor of Medicine and Surgery) from Dundee University, Scotland in 2000. He achieved Membership of the Royal College of Surgeons (Glasgow) in 2004. His research into ‘Hypoxia associated factors’ in oesophagogastric Cancer at Paterson Institute of Cancer Research, Christie Hospital, Wythenshawe Hospital, Manchester, led the award of MD (Doctorate in Medicine) degree from Manchester University in 2006.
Higher surgical training was undertaken in the North West of England, including Specialist Registrar posts in Salford Royal Hospital and Royal Preston Upper Gastrointestinal Units. He obtained his Fellowship of Royal College of Surgeons in 2010 and completion of specialist surgical training (CCT) in 2012. He trained for a year as a Senior Upper Gastrointestinal Fellow in the Royal Adelaide Hospital, Australia. His training in Australia was in the field of advanced laparoscopic surgery for anti-reflux surgery, giant hiatus hernia repairs, upper GI cancer and bariatric surgery.
He joined the Upper Gastrointestinal Surgery unit, as a Consultant, at the University Hospitals Birmingham Foundation NHS Trust in Sept 2012. His main clinical interests are in oesophagogastric cancer, achalasia, hiatus hernia/reflux surgery, and complex oesophageal reconstruction. He is an Honorary Senior Lecturer at the University of Birmingham.
Prof. Dr. Peter Grimminger works as a consultant and head of the Upper gastrointestinal division, including minimal-invasive and robotic surgery, in the Department of General-, Visceral- and Transplantation Surgery of the University Medical Center Mainz, Germany (Chief: Prof. Dr. Hauke Lang).
Previously Dr. Grimminger was working under the supervision of Prof. Dr. Arnulf Hölscher at the University Cologne.
Prof. Grimminger achieved to qualify the department as a national reference center for Surgery of the Stomach and Esophagus and one of only a few “Case Observation Centers” for robotic-assisted minimal-invasive esophageal surgery. As a founding member of the UGIRA (Upper-GI Robotic Association), Prof. Grimminger is also actively involved in exploring new surgical robotic systems, robotic-assisted procedures and techniques.
The publication history of Dr. Peter Grimminger includes over 80 publications including over 30 in the past three years.
Dr. Prakash Gyawali is currently a Professor of Medicine, Director of Neurogastroenterology and Motility, and Program Director of Gastroenterology Fellowship Training at the Division of Gastroenterology, Washington University School of Medicine, St. Louis, USA. Dr. Gyawali's academic interests include gastrointestinal motility, gastroesophageal reflux disease, and functional bowel disorders; he is also prominently involved in the education and mentoring of students, residents, fellows, and peers at all levels. He directs gastrointestinal motility centers affiliated with Washington University and is involved in motility testing using high-resolution manometry, esophageal ambulatory esophageal pH and impedance monitoring, wireless pH monitoring, and endoscopic functional lumen imaging probe (endo-FLIP). He is part of several working groups and consensus committees involving esophageal physiologic testing and has over 250 original publications. He has an extensive academic practice in esophagology and functional bowel disorders and is actively involved in clinical research involving neurogastroenterology and motility.
"Dr. Haidry is a Consultant Gastroenterologist and interventional endoscopist at University College Hospital, London. He trained at St Mary's Hospital in London and completed his Specialist Gastroenterology training in North East London. He was then appointed to a two-year academic fellowship at UCL where he examined state-of-the-art and innovative diagnostic and therapeutic endoscopic techniques for the diagnosis and treatment of early cancers arising in the gastrointestinal tract.
He was appointed as a consultant in 2011. He was until recently the director of endoscopy for the division of gastroenterology at University College Hospital and leads the upper GI interventional endoscopic unit. He is the clinical lead for endoscopy at the London Clinic. His main interests are therapeutic and innovative endoscopic procedures in the upper GI tract. In particular, he has focused his interest in pre-malignant and malignant disorders of the upper gastrointestinal tract, with a particular interest in Barrett’s neoplasia, Squamous neoplasia, oesophageal cancer, metabo-bariatric, and advanced interventional endoscopy. He carries out minimally invasive treatments for acid reflux such as Transoral incisionless Fundoplication (TIF) and Stretta and was among the first UK endoscopists to carry out metabolic and bariatric endoscopic procedures such as Duodenal mucosal resurfacing (DMR) and Endoscopic Sleeve Gastroplasty (ESG).
He also hosts several live endoscopy workshops each year at UCH focusing on novel and innovative endoscopic imaging techniques and therapeutic endoscopic courses focusing on endoscopic resection, radiofrequency ablation, cryo-ablation, endoscopic ultrasound and complex stricture management. He is invited to lecture on his research areas and perform live endoscopy procedures around other units in the world regularly to help learn, share and expand his portfolio.
He has an academic position of Associate Professor at UCL where he supervises his team to generate research into the endoscopic techniques and procedures to improve and streamline the care we give to our patients. His research is focused on existing and novel endoscopic imaging technologies for detecting early cancers such as artificial intelligence. His other main research focus is minimally invasive techniques for treating cancers of the upper gastrointestinal tract and continues to lead and be involved actively on several national and international clinical trials in these fields. One of his main research areas at present is on new and innovative endoscopic procedures for treating Type 2 Diabetes and also for treating patients with obesity with excellent results to date."
Professor George Hanna is head of the Department of Surgery and Cancer at Imperial College and Consultant Upper Gastro-intestinal surgeon at Imperial College NHS Trust. He was trained in Ninewells Hospital, Dundee, Scotland, and obtained a Ph.D. (University of Dundee) in 1997, and FRCSEd (Gen Surg) in 2003. He joined Imperial College as Clinical Senior Lecturer and Upper Gastrointestinal Consultant Surgeon in 2003. His clinical work is based at Hammersmith Hospital and includes oesophageal and gastric cancer and advanced laparoscopic surgery.
Professor Hanna leads the NIHR program for point of care diagnostics in cancer and gastrointestinal diseases (NIHR London IVD). The current interests of his laboratory revolve around volatile organic compounds analysis for biomarker discovery and understanding the molecular drivers of volatile compounds in an attempt to develop a non-invasive breath test to diagnose gastrointestinal cancers. His educational research aims to develop competency assessment tools for training and quality assurance of surgical performance in randomized controlled trials."
Dr. Jaymie Henry is the co-founder and founding Executive Director of the Global Alliance for Surgical, Obstetric, Trauma, and Anaesthesia Care (G4 Alliance), a network of over 300 organizations from 160 countries with a collective impact of over $1 billion in surgical service delivery worldwide. Dr. Henry provided strategic direction for the G4 Alliance from its inception, co-developed its organizational structure, oversaw relations with stakeholders and partners, and organized political and advocacy events in support of essential surgical care at venues such as country offices, permanent missions, the UN, and the WHO. The collective advocacy of the Alliance was instrumental in the passage of the historic 2015 WHO resolution on ‘Strengthening Emergency and Essential Surgical Care as a component of Universal Health Coverage.’
Dr. Henry was a founding member of Forbes Impact and a founding investor at Laudato Si’ Challenge. She was the Executive Director of the International Collaboration for Essential Surgery (ICES) where she led the successful 15x15 campaign to raise the profile of Essential Surgery by 2015, hosted the first United Nations (UN) side event for Essential Surgery as well as the first UN event on surgical care as part of Universal Health Coverage (UHC). She is the Executive Producer, Director, and writer of the Global Surgery advocacy film, The Right to Heal, which has been shown in over 60 countries worldwide and has been reviewed and featured at the Lancet. Dr. Henry was one of the Bellagio Commissioners for the Lancet Commission on Global Surgery. Dr. Henry has advocated for surgical care in international venues such as the UK parliament, Nobel prize winner Muhammad Yunus Social Business conference (Bangladesh), and the World Congress of Surgical, Obstetric, Trauma, and Anaesthesia (Trinidad and Tobago), among others.
Her work has been featured at Newsweek and Forbes as an Icon of Impact. She has more than 20 publications and is a sought-after speaker and lecturer in her field.
Dr. Hirano is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Northwestern University Feinberg School of Medicine. He attended college at Yale University, medical school at the University of Pennsylvania and completed his medical residency and GI fellowship at Beth Israel Hospital in Boston. Prior to a position at Northwestern, he held a faculty position at the West Roxbury VA Medical Center and Harvard Medical School. He recently served as Chair for the American Gastroenterological Association’s Esophageal, Gastric and Duodenal (EGD) section and is currently a site principal investigator for the Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and on the steering committee for International Gastrointestinal Eosinophil Researchers (TIGERS). Dr. Hirano has written over 200 scientific papers and textbook chapters that focus on esophageal and swallowing disorders. He has received grant support from the National Institutes of Health (NIH) and Food and Drug Administration (FDA) for research in eosinophilic gastrointestinal disorders. He received numerous teaching awards from both the division and medical school at Northwestern and has been recognized as a Top Doctor by Chicago Magazine and Best Doctors. He received the Northwestern University School of Medicine Award for Outstanding Achievement in Gastroenterology and Distinguished Service Award.
As a Ph.D. student at the Center of Experimental and Molecular Medicine (CEMM) and the department of gastroenterology and hepatology, Amsterdam UMC, under the supervision of prof. dr. K.K. Krishnadath, Sanne investigated potential biomarkers and clinical characteristics to predict the development of esophageal adenocarcinoma, therapeutic outcomes, and survival in patients with Barrett’s esophagus. Moreover, she investigated transcriptional profiles to distinguish distinct subgroups in esophageal cancer and identified a predictive signature for response to chemoradiotherapy in esophageal adenocarcinoma. During her Ph.D., she worked for 12 months in the research group of prof. K.K. Wang at the division of gastroenterology and hepatology at Mayo Clinic, Rochester, United States of America.
Wayne L. Hofstetter, M.D., is currently Professor and Deputy Chair in the Department of Thoracic and Cardiovascular Surgery and serves as Director of the Esophageal Surgery Program. A graduate of the University of Southern California Medical School, Dr. Hofstetter focused on thoracic surgical disease, completing fellowships in esophageal and foregut surgeries at the University of Southern California, and then thoracic oncology at M. D. Anderson Cancer Center. Broadly trained as a cardiothoracic surgeon and thoracic oncologist at the Texas Heart Institute, he now devotes a great deal of his work to esophageal cancer and lung cancer. At M. D. Anderson, he formed a strong network of clinicians with specific interests in esophageal diseases. A multidisciplinary group emerged under his able leadership, and together, physicians from other specialties like Gastrointestinal Medical Oncology, Radiation Oncology, and Gastroenterology collaborate closely to treat esophageal cancer patients.
Dr. Prasad Iyer attended medical school at All India Institute of Medical Sciences in New Delhi, India. He completed his residency at the University of Wisconsin Medical School in Milwaukee, WI, and his GI Fellowship at Mayo Clinic College of Medicine, Rochester, MN, where he also completed a Postdoctoral Master’s Degree in Clinical Research. Dr. Iyer is a Consultant and Professor in the Barrett’s Esophagus Unit, Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN, where he has been on staff since 2006. He is the Director of the Esophageal Interest Group in the Division of Gastroenterology and a member of the Advanced Endoscopy group. He also directs the Post-doctoral Education Programs in the Center for Clinical and Translational Sciences at Mayo Clinic and is the Co-Director of the Advanced Esophageal Fellowship.
Dr. Iyer is an Associate Editor of the journal Gastrointestinal Endoscopy and the past Chair of the International Committee of the American Society of Gastrointestinal Endoscopy. His clinical and research interests include clinical trials in the early detection, risk stratification, and therapy of Barrett’s related neoplasia and squamous cell carcinoma of the esophagus as well as Endoscopic Ultrasound. His research program is funded by the National Cancer Institute and Foundations. He has published over 200 peer-reviewed articles as well as several book chapters. He is a reviewer for many journals including Gastroenterology, the New England Journal of Medicine, Lancet, Gut, Gastroenterology, American Journal of Gastroenterology, and Clinical Gastroenterology and Hepatology.
Pankaj G. Jani is a G.I.T. Surgeon/Endoscopist, an Educator, trainer, and leader, who has for over 30 years working in Kenya and the ECSA region increasing the surgical capacity through education and training. He works at the Department of Surgery, University of Nairobi (UON) and is an Honorary Consultant Surgeon at the Kenyatta National Hospital, founder member and immediate Past President, College of Surgeons’ East Central and Southern Africa and Vice-Chair, Executive Committee, Interim Board of Directors. G4 Alliance (Baltimore Maryland) He graduated from UON, and after his residency was awarded a Commonwealth Medical Fellowship to train in HPB surgery and G.I. Endoscopy at the Glasgow Royal Infirmary.
His expertise is in Hepato – Pancreatico - Biliary and Laparoscopy Surgery, and therapeutic G.I. Endoscopy. Has been part of the team instrumental in setting up of Laparoscopic Surgery and G.I. Endoscopy in Kenya.
He has been extensively involved with Surgical Training and Health Systems Strengthening in 18 countries in the East Central and Southern Africa region. He has traveled widely both in Africa and abroad with the aim of improving Surgical Training and care of surgical patients in Africa.
Dr Martin Jeremiasen is a senior consultant surgeon in the Esophageal and Gastric unit at Lund University Hospital, Sweden. His clinical work is mainly dedicated to the treatment of benign esophageal and gastric disorders as well as advanced endoscopic treatment of Barretts esophagus and early cancer lesions. His research focuses on register-based data from the Swedish National Register for Esophageal and Gastric Cancer (NREV) and prognostic biomarkers in Upper GI cancer.
Peter J Kahrilas is the Gilbert H. Marquardt Professor in Medicine at Northwestern University’s Feinberg School of Medicine in Chicago where he has worked since 1986. His research is on esophageal pathophysiology, on which he has published more than 400 papers and he is on the editorial boards of Gastroenterology and the American Journal of Physiology. He has served on the AGA Council and Governing Board, as president of the International Society for Diseases of the Esophagus, and currently president of the American Foregut Society. He was elected to the American Society for Clinical Investigation in 1998 and the Association of American Physicians in 2015. He was the recipient of the William Beaumont Prize for lifetime achievement in academic gastroenterology from the American Gastroenterological Association in 2020.
VIVEK KAUL, MD, FACG, FASGE, AGAF
Dr. Vivek Kaul is the Segal-Watson Professor of Medicine and former Chief of Gastroenterology & Hepatology at the University of Rochester Medical Center. His clinical, research, and medical education efforts are focused on Therapeutic Endoscopy/Endosurgery, Interventional Endoscopic Ultrasound, advanced ERCP and esophageal endotherapy for Barrett’s & Esophageal Cancer. He has specific expertise in complex interventional endoscopy, especially in the patient with GI-cancer. He has significant administrative and program development experience and expertise. He is a PI on several national and international trials in pancreatic and esophageal disease.
Dr. Kaul serves on several national committees with the ASGE and the ACG and is a past Governor of the ACG for northern NY. He is Chair of the ACG Innovation & Technology Committee and also Chairs the EUS special interest group (SIG) committee for the ASGE. He is a reviewer for several journals, is a sought-after speaker, and has authored several publications in the field of interventional endoscopy. He also Chairs the World Gastro Organization Endoscopy Committee and regularly lectures and shares his endoscopy expertise at centers in the USA and around the world.
Dr. Kitagawa is a surgical oncologist and a clinical and translational researcher who mainly focuses on the areas of gastrointestinal cancers. He has published 755 articles in English peer-reviewed journals, including 12 original articles in the Annals of Surgery. He is a chair of the Japan Esophageal Oncology Group and works as a principal investigator (PI) for many important nationwide clinical studies, including multimodal treatment for esophageal cancer. He has contributed to the development of minimally invasive and personalized surgical treatment of GI cancer based on sentinel lymph node mapping. His innovative personalized surgical approach for early-stage gastric cancer is now undergoing a multicenter trial. He also acts as PI for an RCT comparing conventional open esophagectomy and thoracoscopic minimally invasive esophagectomy. In recognition of these achievements, he was made an Honorary Member of the European Association for Endoscopic Surgery (2018), the Brazilian College of Digestive Surgery (2009), and the Association of Polish Surgeons (2015).
As an outstanding surgical and multimodal oncologist, he currently serves as the President of the Japanese Society of Gastroenterological Surgery, which has about 20,000 member surgeons. He previously served as the President of the Japan Society of Clinical Oncology, which has about 17,000 members from various fields of cancer care, and as a Vice-Chairman of the Japan Surgical Society (JSS), the largest surgical society in Japan with 40,000 members, for two years and was in charge of the committee of the board certification system of surgeons. He organized the 120th annual meeting of the JSS in 2020 as the Congress President.
He is also active on the international stage, as demonstrated by his contributions as an executive council member of the International Surgical Society, President of the International Society for Diseases of the Esophagus (2016-2018), and an international committee member of the American Society of Clinical Oncology and the Society of Surgical Oncology. He serves as a bridge between the East and the West in the realm of upper GI oncology. As part of this role, he organized the 16th Congress of the International Society for Diseases of the Esophagus in Vienna in 2018 and is now overseeing preparations for the 2023 International Gastric Cancer Congress, which will be held in conjunction with an upper GI oncology summit in Yokohama, Japan.
From 2009 to 2019 he was the Editor-in-Chief of Gastric Cancer, the joint official journal of the Japan Gastric Cancer Association and the International Gastric Cancer Association. He was recently appointed as a new member of the editorial board of the Annals of Surgery. He has also previously served as an editorial advisory board member of Schwartz's Principles of Surgery, an Associate Editor of the official journal of ISDE, Diseases of the Esophagus, and an Associate Section Editor of gastrointestinal oncology for the Annals of Surgical Oncology.
His department covers clinical research and high-volume practice in not only the field of upper GI but also colorectal, hepatobiliary/pancreatic, liver transplantation, breast, cardiovascular, pulmonary, and pediatric surgery. As a program chair of the surgical department of Keio University, he has trained more than 150 surgical fellows since 2007.
As these examples illustrate, he is a very active leader not only in GI surgery and oncology but also across the entire surgical community.
"I am a gastroenterologist with a special interest in advanced endoscopic resections of early GI cancers. Research topics include expanding the limitations of endoscopic resections and advanced training."
Vani Konda is gastroenterologist with clinical expertise in esophageal disorders. Her clinical practice focuses on esophageal diseases including Barrett's esophagus, eosinophilic esophagitis, reflux, esophageal strictures, achalasia, and swallowing disorders.
Prof. Dr. Sheila Krishnadath is a Clinician/Researcher specialized in translational studies on Barrett’s esophagus. In her daily practice as a gastroenterologist, her focus is on premalignant an mn malignant esophageal diseases. Her translational Research line is focused on the development of preventive strategies by the implementation of biomarkers and the development of targeted/chemopreventive therapies.
Dr Sunil Kumar, MS FACS is currently working as an Additional Professor of Surgical Oncology at the All India Institute of Medical Sciences which is the most prestigious academic tertiary care hospital in India. His primary area of interest is thoracic cancers and he was given the responsibility to start a comprehensive thoracic surgical oncology program at the Institute encompassing the multimodality management of malignant diseases involving esophagus, lung, chest wall, mediastinum, and pulmonary metastatic tumors.
One of the areas having his prime emphasis is low-cost delivery of surgical treatment in the context of constraints in low and middle-income countries through evaluation of alternative protocols of neo-adjuvant chemotherapy for esophageal cancer. His team is also trying to study methods to predict the chemotherapy response through whole-exome analysis.
He is also part of the national cancer registry program of India particularly looking into aspects of patterns of care and survival analysis in cancer.
Coming from a humble background, he started a non-profit organization that is trying to bring basic cancer care services to some of the poorest parts of the population in Bihar (a province in India).
Simon Law graduated from the University of Cambridge in England with First Class Honors. He received his post-graduate training at the Department of Surgery at The University of Hong Kong. He is currently Cheung Kung-Hai Professor in Gastrointestinal Surgery, and Chair Professor and Chief of Esophageal and Upper Gastrointestinal Surgery at The University of Hong Kong.
Professor Law has been playing an active role in many international societies; He is co-chairman of the Education Committee of the International Society of Diseases of the Esophagus and the current Vice-President of the society. He is an honorary fellow of the American Surgical Association as well as the European Surgical Association.
He has concentrated his experience and research on both benign and malignant upper gastrointestinal tract disorders. He has published over 300 articles and 40 book chapters. He is associate editor of Diseases of the Esophagus and is/has been a member of the editorial board in 15 other journals, including Annals of Surgery, JAMA Surgery, Surgery and World Journal of Surgery. He has been invited as visiting professor and to deliver keynote and plenary lectures worldwide. He has spoken nationally and internationally on over 360 occasions.
Zhigang Li, M.D., Ph.D., is the deputy chief of Division of Thoracic Surgery and the director of Esophageal Surgery Section at Shanghai Chest Hospital. He also serves in lots of academic positions in China, such as the Director of Esophageal Surgery for Shanghai Thoracic Surgeons Association, and the Vice-director of the Esophageal Surgery for Chinese Thoracic Surgeons Association.
After completing "The Evarts A. Graham Memorial Traveling Fellowship" training program in the United States, he established the Esophageal Surgery Section in Shanghai Chest Hospital in2015 and has made it to be the largest program in Shanghai. He is dedicated to the minimally invasive surgical treatment of esophageal diseases and established the world's largest robotic-assisted esophagectomy program. As a surgeon with a wide range of academic interests, he also pioneered the development of Chinese magnetic sphincter augmentation (MSA) for GERD treatment in China. At the same time, he is committed to a large number of clinical studies, such as PreSINO, RAMIE, AdESD, and NICE trial.
Shulin Li is a third-year Ph.D. student at the University Medical Center of the University of Amsterdam. His main research interest centers on how BMP2 and 4 effect on SMAD4 negative esophageal adenocarcinoma (EAC). His current research is that selective targeting of BMP2/4 improves survival of SMAD4 negative EAC in a patient-derived tumor xenograft (PDTX) model.
Dr. Steven Lin is an Associate Professor and Physician-Scientist at MD Anderson Cancer Center. Dr. Lin oversees several clinical trials including the use of proton beam therapy for esophageal cancer and in the combination of immunotherapy with radiotherapy in lung and esophageal cancers. Dr. Lin also evaluates biomarkers for treatment response and disease outcomes after chemoradiation therapy and immunotherapy.
Donald Low, MD is the Director of the Esophageal Center of Excellence at the Digestive Disease Institute, President of the Ryan Hill Research Foundation, and Chief of Thoracic Surgery and Thoracic Oncology at Virginia Mason Medical Center.
Dr. Low’s clinical interests include all aspects of general Thoracic Surgery but are focused on the treatment of Esophageal Cancer, Barrett’s esophagus, benign tumors of the esophagus, primary and revisional antireflux surgery, paraesophageal hernia, and achalasia.
Dr. Low is a Board Certified General Thoracic Surgeon, Fellow of the American College of Surgeons, and a Fellow of the Royal College of Surgeons of Canada. He has received Honorary Fellowships from the Royal College of Surgeons of Ireland, the Royal College of Surgeons of England, and the Royal College of Surgeons of Edinburgh. His research interests have focused on the improvement in pathways of care associated with esophagectomy and he is responsible for the ERAS Society Guidelines associated with esophagectomy. His other major research interests include assessing the importance of body composition on outcomes in patients with esophageal cancer and in standardizing outcome reporting and definitions associated with the surgical treatment of esophageal cancer. He is responsible for the formation of the Esophageal Complications Consensus Group (ECCG) and the International Online Esodata database and is President of the International Esodata Study Group (IESG).
You-sheng MAO；MD, Professor of Thoracic Surgery, Director of First Division, Department of Thoracic Surgery, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China; Chairman designate of Chinese Committee for Esophageal Cancer; Pre-president of Chinese Society for Diseases of Esophagus(CSDE); Membership of UICC and ISDE.
Graduated from Xiangya Medical College in 1984 and have been working in the field of thoracic surgical oncology. UICC fellowship (1997~1999), in the Department of Cardiovascular and Thoracic Surgery, University of Maryland Medical School, USA.
During the past 37 years of clinical work, I have accumulated rich clinical experience in dealing with tumors of the lung, esophagus, gastric cardia, and mediastinum as well as chest wall through either VATS or mussel sparing incision. As principal investigator, I participated in a lot of clinical trials and basic research projects on lung and esophageal cancer. I have published more than 60 scientific papers in first-class domestic and overseas medical journals. As the first co-editor, I edited two professional books: “ Thoracic Surgical Oncology” and “Clinical Oncology”.
Sheraz R. Markar, PhD (Imperial), PhD (Karolinska), MRCS, MSc, MA. Senior Oesophago-Gastric Fellow, Oxford University Hospitals NHS Trust, UK & Assistant Professor, Karolinska Institutet, Sweden.
From 2018 Scientific Director at IRST IRCCS Cancer Center Italy.
His main research and clinical activity involve the area of acute and chronic myeloid leukemia and myelodysplastic syndromes.
Expertise: Conduction of several Phase I-II-III clinical trials and biological research projects on AML, LAL, MDS, and CML as Principal Investigator. His research and clinical activities are devoted to translational studies mainly on acute leukemia focusing on the molecular characterization of acute leukemia primary samples using NGS and SNP arrays technologies. Different translational projects are currently integrating genomics data with functional analyses in order to identify novel genetic alterations and evaluate them as potential targets for innovative therapies.
Expertise and authority to lead a team and he has the capacity of using the resources in a flexible way to achieve the project objectives.
He has been involved in the different international projects:
-FP7-HEALTH-2012-INNOVATION-1 Seventh framework program 2011 Principal Investigator of the financed International project: “Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia - NGS-PTL”.
-Coordinator of WP5 of the IMI2 Call topic identifier H2020-JTI-IMI2-2015-06-two-stage project named Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms In HematologY (HARMONY)
-Partner and WP4 coordinator of the ERA-PER MED call 2018 project: Synthetic Lethality for Personalized Therapy-based Stratification In Acute Leukemia
Sandro Mattioli is a professor of the Alma Mater Studiorum-University of Bologna ( honorary title ), director of the Division of Thoracic Surgery at the Maria Cecilia Hospital, in Italy. His professional and research career was developed in Bologna and Toronto ( Division of Thoracic Surgery). He is the author or co-author of over 700 scientific products, in the majority on esophageal diseases. His specific research has focused on the pathophysiology of GERD ( 3 probe esophago-gastric prolonged Ph recording and GERD after migration of the GEJ into the chest ), esophageal achalasia (intraoperative manometry), parenteral and enteral nutrition in patients submitted to esophagectomy. He is the proponent (1978-81) of the Heller-Dor operation according to specific principles of surgical physiology, of two surgical procedures for therapy of true short esophagus ( the laparoscopic- left thoracoscopic Collis-Nissen and the SASF –stomach around stomach fundoplication). He is actually the coordinator of EACSGE, Esophageal Adenocarcinoma Study Group Europe. He has personally performed over 3500 major procedures of esophageal surgery.
Dr. Gary May received his MD from the University of Alberta in Edmonton, Alberta, Canada(1985), completed his internship and internal medicine training at the University of British Columbia, and his Gastroenterology training at the University of Calgary (1991). Dr. May completed his fellowship training in biliary and advanced therapeutic endoscopy at Duke University Medical Centre, Durham, North Carolina under the mentorship of Dr. Peter Cotton(1993). From 1993 to 2004, Dr. May was on the faculty at the University of Calgary where he practiced at the Foothills Hospital. In 2004, Dr. May was recruited to St. Michael's Hospital where his interests as a clinician teacher are in advanced therapeutic endoscopy including ERCP, endoscopic ultrasound, and endoscopic oncology including advanced EMR, POEMS and ESD. He is a co-director of the successful International Therapeutic Endoscopy Course held annually at St. Michael’s Hsopital. He is currently the head of the Division of Gastroenterology at St. Michael’s Hospital.
Sumeet Mittal, MD, is a board-certified general surgeon and Surgical Director of the Esophageal and Foregut Program at Norton Thoracic Institute, St. Joseph’s Hospital and Medical Center.
Dr. Mittal is an expert in many esophageal diseases, and his research interests include diseases of the esophagus and the foregut. He is a member of the Society of American Gastrointestinal and Endoscopic Surgeons, the Society of Laparoscopic and Endoscopic Surgeons, and the American Society for Gastrointestinal Endoscopy.
After earning his medical degree from the All Institute of Medical Sciences in New Delhi, India, he completed his residency at Creighton University. Dr. Mittal also did a fellowship in thoracic and foregut surgery at the University of Southern California in Los Angeles. Before he joined the team at Norton Thoracic Institute, he was the Director of Esophageal Surgery at Creighton University School of Medicine.
Dr Paul Moayyedi qualified from Bristol University and obtained a PhD and Masters in Public Health from the University of Leeds. He moved to McMaster University in 2004 and was Director of the Division of Gastroenterology at McMaster in 2006-2017. He holds the Audrey Campbell Chair of Ulcerative Colitis Research and is currently the Assistant Dean of Research at McMaster University. He has published over 425 peer-reviewed articles that have been cited over 59,500 times with an h index of 119. He was Co-Editor in Chief of the American Journal of Gastroenterology 2010-2015. He is a proponent of evidence-based medicine and was involved in a randomized trial assessing the harms of PPI therapy as well as the impact of PPI on Barrett's esophagus.
Dr. Daniela Molena is a graduate of the University of Padova Medical School in Italy. She completed residencies in general surgery both at the University of Padova and the University of Rochester Medical Center in Rochester, NY. She completed a gastrointestinal research fellowship at the University of California in San Francisco and cardiothoracic clinical fellowship at Memorial Sloan Kettering Cancer Center (MSKCC) and Weill Cornell Medical College. She serves as the Director of the Esophageal Program at Memorial Sloan Kettering Cancer Center in New York.
Dr. Molena has authored over 100 manuscripts. She is part of the Editorial Board of several renowned Journals. She is Member of the American Surgical Association, Fellow of the American College of Surgeons, member of the Society of Thoracic Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, Society for Surgeons of the Alimentary Tract, American Association for Thoracic Surgery and International Society for the Diseases of the Esophagus. She holds leadership positions in several of these surgical societies and is Vice President of the Women in Thoracic Surgery.
Dr. Mueller completed a residency at the University of Toronto and fellowship in advanced minimally invasive and foregut surgery at McGill University. Her high-volume clinical practice focuses on the management of the complex benign and malignant gastroesophageal disease. She is highly active in residency education and clinical outcomes and surgical education research.
Dr. Michael Mwachiro is a consultant General surgeon at Tenwek Hospital, Bomet, Kenya. He is currently the Director of the endoscopy department and the Program Director for the Tenwek General Surgery training program. He is the Secretary General of the Surgical Society of Kenya. His research interests include esophageal cancer treatment and palliation, esophageal squamous dysplasia, and surgical education. He is a founder member of the African Esophageal Cancer Consortium (AfrECC)
Dr. Jennifer Myers is a Senior Clinical Scientist and Senior Lecturer at The Queen Elizabeth Hospital and the University of Adelaide in South Australia. She has clinical and research interests in esophageal motility disorders, gastro-esophageal reflux disease, and upper GI surgery, including fundoplication, cardiomyotomy, and bariatric surgery. In 2012, she received the Australian Society of Medical Research young investigator Ross Wishart Award, for her Ph.D. research evaluating factors that contribute to increased risk of troublesome dysphagia after anti-reflux surgery. Identifying factors such as esophageal ileus; intrabolus pressure; crural repair and luminal pressure-flow relationships.
Dr. Myers engages in national and international research collaboration, as well as authoring research and review publications. She has a keen interest in guiding young doctors in surgical research and commits often to providing support and education to consultant physicians and surgeons embracing the challenges of esophageal function testing.
Dr. Myers works in Esophageal Function in Health and Disease in Adelaide, Australia.
Magnus Nilsson is a Professor of surgery at Karolinska Institute, Stockholm Sweden, and an expert in gastric and esophageal cancer surgery, especially in minimally invasive techniques. His main research interests are focused on optimizing surgical and oncological outcomes in esophageal cancer and he has led several multicenter randomized controlled trials in the field.
Started VATS at 1995. Completed about 800 VATS according to microanatomy of mediastinum.
Dr. Pandolfino is the Hans Popper Professor of Medicine and Chief of Gastroenterology and Hepatology at the Feinberg School of Medicine at Northwestern University. His career has focused primarily on studying the biomechanics of bolus transport and gastrointestinal motility as it pertains to gastroesophageal reflux and swallowing disorders. He currently is funded by the NIH to study GERD and Dysphagia pathogenesis and also receives funding from the industry focused on the development of new technologies to investigate and treat gastrointestinal disorders. He maintains a strong clinical practice in the Northwestern Medicine Esophageal Center. He is active in multiple professional organizations, serves on multiple editorial boards and is currently the President of the American Neurogastroenterology and Motility Society.
Did General Surgery at UCSF. Esophageal Fellowship in Hong Kong. Co-Director Center for Esophageal Diseases at UCSF (1994-2007), University of Chicago (2008-2016), UNC (2016-present). Past President of the International Society for Digestive Surgery and the International Society of Surgery. He has published 300 peer-reviewed manuscripts and 6 books.
Dr. Manuel Pera is Professor of Surgery and Head of the Section of Gastrointestinal Surgery of the Department of Surgery at the Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
He completed his training in General and Digestive Surgery at the Hospital Clinic of Barcelona and fellowships at the Division of General Thoracic Surgery, Mayo Clinic, Rochester, and the Division of General Thoracic Surgery, Hôtel-Dieu de Montreal, Canada.
His clinical interest includes benign and malignant diseases of the esophagus and stomach. His research interest includes gastroesophageal carcinogenesis, Barrett´s esophagus, and prognostic markers in gastric and esophageal cancer.
He is past President of the European Society for Diseases of the Esophagus and Associate-Editor of the official journal of ISDE “Diseases of the Esophagus”. Professor Pera is also serving as coordinator of the Spanish EURECCA Upper GI Cancer Registry. He has authored more than 170 articles and book chapters.
Roos Pouw is a gastroenterologist at the Amsterdam University Medical Centers (former AMC and VUmc), the Netherlands. In 2011 Roos obtained her PhD-degree Cum Laude with her thesis entitled “Endoscopic eradication of Barrett’s esophagus with early neoplasia.” Next to her clinical work, Roos supervises a number of research lines on endoscopic management of early Barrett’s neoplasia, and for this work she received the UEG Rising Star award 2020.
Dr. Matthew Read is a general and upper gastrointestinal surgeon. After completing his general surgical fellowship in 2016, Matthew was accepted by the Australian and New Zealand Gastro-Oesophageal Surgery Association for subspecialty training in the field of upper gastrointestinal surgery. Following this, Matthew completed a combined clinical and research fellowship at the University Medical Centre in Utrecht, the Netherlands. Upon returning to Australia, Matthew has taken up a combined clinical and academic position through both the University of Melbourne and St Vincent’s Hospital where he is in the process of establishing a research program.
Matthew also has a background in basic and translational research, having completed a Ph.D. through the University of Melbourne and the Peter MacCallum Cancer Centre, which was focused on the development of preclinical models to better understand oesophageal cancer and its precursor, Barrett’s oesophagus. This work has led to numerous publications, awards, and international collaborations. Matthew is the current recipient of the senior lecturer fellowship from the Royal Australasian College of Surgeons and serves as the younger fellow representative on the Academic Surgery Committee.
Professor Reynolds is Academic Head of Clinical Surgery at St. James’s Hospital and Trinity College Dublin. He is the National Lead in Ireland for oesophageal and gastric cancer. He is Cancer Lead at the Trinity St James’s Cancer Institute, and a Principal Investigator in the Trinity Translational Medicine Institute. He is President of the Irish Society of Clinical Nutrition and Metabolism (IRSPEN). He has formerly held Fellowship positions with the University of Pennsylvania and Wistar Institute in Philadelphia and at the Memorial Sloan-Kettering Cancer Centre in New York. He was a Senior Lecturer at St. James’s University Hospital in Leeds (1994-6).
Professor Reynolds has obtained numerous research awards and has published widely in cancer research, with over 400 publications and approximately €5m research grant income.
His clinical interest is in diseases of the oesophagus and stomach. His research interest is in six principal areas: (1) pathogenesis of Barrett’s oesophagus and progression; (2) prediction of response and resistance to chemotherapy and radiation therapy; (3) obesity, non-alcoholic fatty liver disease, altered metabolism, and cancer; (4) malnutrition and peri-operative nutrition; (5) multimodal enhanced recovery after surgery (ERAS) pathways; and (6) cancer clinical trials, he is PI for the NeoAEGIS RCT in oesophageal adenocarcinoma.
Associate Professor of Digestive Surgery. Surgical Coordinator of the Cancer Institute, Universidade de Sao Paulo (ICESP-HCFMUSP)
Currently heading the highest volume center for esophageal surgery in Italy with more than a hundred esophagectomy per year.
I currently Head the Upper GI surgical unit at the Christian Medical College Hospital, Vellore, India. Having completed my basic surgical training in India, I underwent Upper GI surgical Fellowship training in Australia, and I'm a current fellow of the Royal Australasian College of Surgeons (RACS). My areas of clinical interest include surgery for benign and malignant diseases of the esophagus and stomach and advanced laparoscopic surgery.
I have been actively involved with the various upper GI surgical societies of India, including the Indian Association of Surgical Gastroenterology (IASG) and the Indian Society of the diseases of esophagus and stomach (ISES). Having authored more than 80 journal publications and book chapters, I have participated as invited faculty in various national and international surgical conferences. I have been involved with basic and clinical research projects in relation to Upper GI Surgery and received major grants from the ICMR (Indian Council of Medical Research) for clinical research in relation to cancer of the esophagus. Current examiner for the National Board of examinations in India and the Royal College of Surgeons of Edinburgh.
Inderpal S. Sarkaria, MD., FACS., is an internationally recognized thoracic surgeon with extensive expertise and experience in minimally invasive and Video Assisted Thoracic Surgical (VATS) approaches including esophagectomy for esophageal cancer, VATS lobectomy for lung cancer, VATS thymectomy for thymoma, laparoscopic anti-reflux surgery for GERD, laparoscopic surgery for achalasia, and laparoscopic repair of giant paraesophageal hernias (GPEH). Dr. Sarkaria is renowned as a leader and innovator in the development of robotic-assisted surgery for thoracic diseases and, prior to coming to UPMC, pioneered efforts to develop these approaches at Memorial Sloan-Kettering Cancer Center in New York.
Board-certified in general surgery and thoracic surgery, Dr. Sarkaria earned his medical degree from the University of Medicine and Dentistry of New Jersey in Newark. He completed a residency in general surgery and cardiac surgery fellowship at New York Presbyterian Hospital – Weill Cornell Medical Center. He also completed fellowships in thoracic surgical oncology and cancer research at Memorial Sloan-Kettering Cancer Center and an additional fellowship in minimally invasive thoracic surgery at UPMC. Dr. Sarkaria currently serves as Associate Professor of Cardiothoracic Surgery, Chair in Minimally Invasive Thoracic Surgery, Vice Chairman of Clinical Affairs, Director of Thoracic Robotic Surgery, and Co-Director of the Esophageal and Lung Surgery Institute and C-Director of Thoracic Surgery Quality and Outcomes at UPMC, he obtained his MBA in 2019.
Prof. Edoardo Vincenzo Savarino received his Medical and Ph.D. degrees from the University of Genoa, Genoa, Italy, in 2004 and 2009, respectively. From 2004 to 2011, he completed his residency training in internal medicine and fellowship training in gastroenterology, hepatology, and endoscopy at the Department of Internal Medicine, Azienda Ospedaliera-Universitaria San Martino of Genoa. In 2011, he became an Assistant Professor at the University of Padua. Presently, he is an Associate Professor of Gastroenterology at the University of Padua. He is mainly interested in neurogastroenterology, motility, pathophysiology, and immune-mediated diseases of the gastrointestinal tract. He has published extensively (h-index 39, published papers n=240) on gastroesophageal reflux disease (GERD), esophageal motility disorders, Barrett’s Esophagus, functional disorders (functional dyspepsia, irritable bowel syndrome), achalasia, eosinophilic esophagitis, new methodologies of esophageal function testing, H2-breath tests, and inflammatory bowel diseases. He received various prizes for his work from UEG Federation, OESO Foundation, ISDE, Società Italiana di Gastroenterologia ed Endoscopia. He is reviewer for several journals, including New England Journal of Medicine, American Journal Respiratory and Critical Care Medicine (AJRCCM), Gastroenterology, Gut, Alimentary Pharmacology and Therapeutics (APT), Clinical Gastroenterology and Hepatology (CGH), American Journal of Gastroenterology, UEG Journal, Journal of Gastroenterology and Hepatology (JGH) and Neurogastroenterology and Motility (NMO).
I am a gastroenterologist and professor of medicine at the University of North Carolina School of Medicine and Chief of the Division of Gastroenterology and Hepatology at UNC. I specialize in endoscopic treatment of precancerous and cancerous conditions of the esophagus and am an active clinical researcher in these areas.
Dr. Sharma has been at the forefront in improving the diagnosis and management of GI diseases and cancer, specifically in esophageal diseases, GERD, Barrett’s esophagus, advanced imaging, and endoscopic treatments. He is a world-renowned physician, teacher, and educator.
Dr. Sharma has been interviewed by the Wall Street Journal and Newsweek. He has over 400 publications, including original articles and book chapters, and is regularly invited to present at major national and international meetings. In addition, he has co-edited several important books.
Peter D. Siersema, MD, PhD is Professor of Endoscopic Gastrointestinal Oncology at the Radboud University Medical Center, Nijmegen, The Netherlands.
His clinical interests include pre-malignant and malignant diseases of the gastrointestinal tract, especially Barrett’s esophagus and esophageal cancer. Dr. Siersema is Past-President of the European Society for Diseases of Esophagus (ESDE) and is Editor-in-Chief of the journal Endoscopy
He has authored more than 700 peer-reviewed papers and chapters in books and has edited more than 20 books.
Professor of Anesthesia, the University of Toronto, member of the Anesthesia Staff Toronto General Hospital. Area of interest: Anesthesia for Thoracic Surgery, with specific interests in pre-operative assessment, lung isolation, management of one-lung ventilation, and perioperative lung injury. Has edited, authored, and co-authored numerous texts, articles, and chapters relating to Thoracic Anesthesia. Associate Editor for Thoracic Anesthesia, Journal of Cardiothoracic and Vascular Anesthesia.
Director, Upper GI Surgical unit, Princess Alexandra Hospital. Past President, Australia and New Zealand Gastric and Oesophageal Surgeons Association. Mayne Professor of Surgery, University of Queensland. Past Chair, Section of Academic Surgery, Royal Australasian College of Surgeons. Executive, International Gastric Cancer Association.
Since 2004 Chairman of Swiss EoE Research Group
Since 2016 Chairman of EoE Swiss Clinics, Dept. of Gastroenterology, University Hospital; Zuerich, Switzerland
For Publications please see Pubmed "Straumann A"
Catherine Streutker obtained her BSc at the University of Waterloo in Biochemistry (1989). She then earned a Master's degree in Clinical Biochemistry at the University of Toronto (1991). She entered medical school also at the University of Toronto and graduated in 1994. She completed her Anatomic Pathology Residency program at the University of Toronto in 1999. After this, she completed a two-year fellowship in Gastrointestinal Pathology with Dr. R. Riddell and Dr. K. Croitoru at McMaster University. In 2001, she joined St Michael’s Hospital and the Department of Laboratory Medicine and Pathobiology at the University of Toronto as a gastrointestinal pathologist. Her research interests are primarily mucosal immunology, Barrett’s esophagus, and tumours of the upper gastrointestinal tract. She is presently the Deputy Chief of Laboratory Medicine group at St. Michael's Hospital and Vice-Chair of Promotions and Mentorship at the University of Toronto.
Monisha Sudarshan, MD, MPH, FRCSC, is a thoracic surgeon and director of operations for the Department of Thoracic Surgery at Cleveland Clinic.
She specializes in treating benign and malignant conditions of the esophagus.
Dr. Sudarshan received her medical degree from McGill University Faculty of Medicine, Montreal, Quebec, Canada. She completed her general surgery residency at McGill University Health Center from 2010 to 2016 and also earned a Master’s in public health from Harvard University, Cambridge, Mass., in 2013. Dr. Sudarshan served her fellowship in cardiothoracic surgery at Mayo Clinic in 2019.
Dr. Sudarshan has authored and co-authored papers on surgical outcomes research published in leading medical journals, particularly in relation to surgical treatment for esophageal diseases. She has presented this research at leading medical meetings in the United States, Canada, Italy and China. She has co-authored chapters in six surgical handbooks and reference works.
Professor of Surgery, FACS, AATS member
A/Prof Sarah Thompson is a consultant upper gastrointestinal surgeon at Flinders Medical Centre, and an academic surgeon at Flinders University. She completed her surgical residency in Calgary, Alberta prior to completing 2 fellowship years in Minimally Invasive Surgery at OHSU in Portland, Oregon under Dr. John Hunter, and in Adelaide, South Australia, under Professor Glyn Jamieson.
Practices at. Jefferson Gastroenterology/Hepatology in Philadelphia. She is also the co-director of The Jefferson Complex Colon Polyp Center and The Jefferson Barrett's Esophagus Treatment Center. She holds a teaching position in the Sidney Kimmel Jefferson Medical College helping to educate first and second-year medical students in the classroom as well as in the clinic. She won this year’s GI Division teaching award from the GI fellowship class of 2020.
Dr. Tofani is actively involved in the American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy, being on a number of committees and providing state-of-the-art lectures on women's issues in medicine as well as advanced endoscopic treatments.
She has published in a variety of areas, but most extensively on Barrett's esophagus. She is the principal investigator or co-principal investigator on a number of important ongoing national trials in Barrett's esophagus.
Dr. Vaezi is currently a Professor of Medicine and Otolaryngology at the Vanderbilt University Medical Center in the Division of Gastroenterology, Hepatology, and Nutrition. He is the Associate Chief and Clinical Director of the Division and Director of Center for Swallowing and Esophageal Disorders and Director of Clinical Research. He is immediate past Chair of the EGD Section of the AGA and is currently Associate Editor for Gastroenterology and member of the AGA research Council.
Dr. Vaezi received a B.S. degree in Chemistry at Birmingham-Southern College in Birmingham, Alabama. He then went to the University of Alabama at Birmingham and received his Ph.D. in Bio-Organic Chemistry. From there, Dr. Vaezi went to the University of Alabama School of Medicine where he received his MD degree in 1992. He completed a four-year academic residency in internal medicine in a program focused on clinical research at the University of Alabama Hospitals in Birmingham Alabama. Subsequently, he completed his fellowship in Gastroenterology at the Cleveland Clinic Foundation where he was elected as the Chief Fellow. He also received a Master’s in Epidemiology and Clinical Research from Case Western Reserve University.
Dr. Vaezi is an associate member of the American Gastroenterological Association and a Fellow member of the American College of Gastroenterology.
"Professor dr. Mark I. van Berge Henegouwen is chair of the upper GI unit at the Amsterdam University Medical Centers, chair of the Dutch Upper GI Cancer Audit and chair of the Dutch society of foregut surgeons of the Netherlands. He was appointed professor of Gastrointestinal Surgery in 2017 at the University of Amsterdam.
Mark van Berge Henegouwen, s, received his MD and PhD at the University of Amsterdam. He performed his fellowship in gastrointestinal and minimally invasive surgery at the Academic Medical Center in Amsterdam where he started as senior consultant in 2006.
Mark van Berge Henegouwen’ s clinical practice is dedicated to patients with malignancies of the esophagus and stomach. The Amsterdam UMC is currently one of the largest centers for esophageal and gastric cancer in Europe. The Amsterdam UMC is a tertiary referral center for these patients with around 250 esophago-gastric resections annually. Mark van Berge Henegouwen has introduced minimally invasive surgery for esophageal and gastric cancer at his center in 2009 and now around 90 percent of patients is treated thoraco-laparoscopically or robotically.
Mark van Berge Henegouwen is a Principal Investigator in upper GI cancer Surgery and main research activities are focused on improvement of outcomes in upper GI cancer surgery, outcomes and centralization in the Dutch Upper GI Cancer Audit, improvement of (minimally invasive) techniques, neoadjuvant treatment regimens in esophageal and gastric cancer and quality of life in upper GI cancer surgery."
Richard van Hillegersberg attended medical school in Rotterdam, the Netherlands. In 1990 he received a research grant from the Dutch Digestive Foundation, that enabled him to perform Ph.D. research on the local treatment of liver metastases at the Department of Surgery, Erasmus MC in Rotterdam. In 1993 he received his Ph.D. with honor. After obtaining his MD in 1994, he was a resident of Surgery in Rotterdam and was registered as a general surgeon in 2000. From 2001-2002 he was a fellow of Surgical Oncology in the Academic Medical Center and Antoni van Leeuwenhoek Netherlands Cancer Center Amsterdam. Since 2003 he is appointed as a staff surgeon at the University Medical Center Utrecht. Since 2009 he is a full professor of gastrointestinal oncology and program leader of the GI-Oncology department. His clinical interests are upper gastrointestinal tract and hepatobiliary surgery. Research is focused on minimally invasive and robotic surgery, surgical imaging, genetic profiling for cancer. He has authored and co-authored over 300 articles in international peer-reviewed journals. He is past president of the Dutch GI Surgical Association, past board member of the Dutch Surgical Association, last board member of the Dutch Society for liver surgery. Past president of the Dutch Upper GI Surgery and President of European Digestive Surgery. He is president of ESSAT and council member of UEG and ESDE. He is president of the Upper GI International Robotic Association (UGIRA).
J.J.B. (Jan) van Lanschot (1953) is currently Professor of Surgery at the Erasmus Medical Centre and Erasmus University, Rotterdam, the Netherlands.
He qualified from the University of Utrecht (1980) and trained at the University Hospital Rotterdam-Dijkzigt (1982-1988), where he wrote his academic thesis on "Metabolic gas exchange in critically ill surgical patients".
He spent one year as a basic research fellow with Professor Douglas Wilmore at the Brigham and Women's Hospital (Harvard Medical School, Boston, USA). From 1989 to 1992 he was an assistant professor at the University Hospital Rotterdam-Dijkzigt, where he had postgraduate training in upper GI surgery and in colorectal surgery. In 1993 he became associate professor of surgery in the Academic Medical Centre at the University of Amsterdam where he was appointed Professor of Surgical Oncology in 1999.
In 2007 he returned to the Erasmus Medical Centre in Rotterdam where he became chairman of the Department of Surgery (2007-2012).
He has held/holds a variety of managerial and executive positions both locally and (inter-) nationally including program director for Surgical Training at the AMC in Amsterdam, chairman of the Dutch Society of GI Surgery, board member of the Dutch Society of Surgery, chairman of European Digestive Surgery, chairman of the European Society for Diseases of the Esophagus, and secretary-general of the European Surgical Association.
He is an editorial board member of several scientific journals, including the British Journal of Surgery, Digestive Surgery, Diseases of the Esophagus, and the World Journal of Surgery.
He is an honorary member of the Dutch Society of GI Surgery, the Polish Society of Surgical Oncology, the Royal College of Surgeons of Edinburgh, the German Society of General and Visceral Surgery, the Murcian Society of General and Visceral Surgery, the Brazilian College of Digestive Surgery, the European Society for Diseases of the Esophagus and the Royal College of Surgeons in Ireland. He received named honorary medals of the Dutch Society of Gastroenterology (Frieda den Hartog Jager award), the Swedish Society of Medicine and Surgery (Bengt Ihre award), the Catalan Society of Surgery (Gimbernat award), and the Royal College in Ireland (Colle's medal).
His research interests currently lie mainly in the field of oesophago-gastric surgery and particularly upper GI cancers. He has published more than 300 peer-reviewed articles and more than 50 books/book chapters.
Kenneth K. Wang is the Russ and Kathy Van Cleve Professor of Gastroenterology Research at the Mayo Clinic Rochester. His research focus is on the diagnosis and treatment of Barrett's esophagus and esophageal cancer. He was involved in the original studies that led to the clinical use of photodynamic therapy and radiofrequency ablation. His research focus has been on novel imaging, ablation, and mucosal resection techniques. His research on the pathogenesis of Barrett's esophagus has been supported by the NIH for the past 27 years. He was a co-editor in chief of Diseases of the Esophagus and a former president of the ISDE.
Sachin Wani, MD is a Professor of Medicine at the University of Colorado Anchutz Medical Campus. He serves as the Associate Medical Director in the Division of Gastroenterology and Hepatology and the Medical Director of the Esophageal and Gastric Center. His research focuses on Barrett's esophagus and esophageal adenocarcinoma, outcomes research and education and training in endoscopy.
Professor Watson is Professor and Head of Surgery at Flinders University, and an Oesophagogastric Surgeon at Flinders Medical Centre in Adelaide, South Australia. He is President of the International Society for the ISDE.
Prof. Wenqiang Wei is currently the Director of the National Central Cancer Registry, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, China. He has been engaged in cancer epidemiology and comprehensive prevention and control in high-risk areas for over 20 years. As PI, he hosted 17 national/international projects focus on study etiology, primary intervention, and early detection of Upper GI cancers through multidisciplinary and global collaborations. He also holds the representative of the Asian Regional Committee of the International Association for Cancer Registration, the Consultant of the WHO Working Group on the Coordination Mechanism for the Prevention and Control of NCD, the member of expert consultant committee, Disease Prevention and Control Bureau of National Health Commission, China, and member of other 8 academic associations/Committees. He has published more than 100 academic papers in professional journals such as Nature Genetics, JCO, Gut, Gastroenterology, and so on.
Bas Wijnhoven is appointed as staff surgeon at the Erasmus MC Rotterdam and is program leader on oesophageal and gastric diseases. His clinical and research interests are benign and malignant diseases of the upper gastrointestinal tract. He also has an interest in medical publishing and serves as editor for BJS.
Dr. Yahagi is a professor of medicine and a director, division of research and development for minimally invasive treatment at cancer center, Keio university school of medicine. He is one of the pioneer of ESD technique and an inventor of many devices for ESD including flex knife and dual knife.
Giovanni Zaninotto is currently Visiting Professor at Imperial College. He was previously a Clinical Senior Lecturer at Imperial College and a Professor of Surgery at the University of Padova. His main interests are benign esophageal disorders, esophageal physiology, Barrett’s esophagus. He is Co-editor in Chief of the Journal Diseases of the Esophagus